OTCMKTS:MLCPF Medipharm Labs (MLCPF) Stock Price, News & Analysis $0.06 +0.01 (+11.76%) As of 03/11/2025 Add Compare Share Share Stock Analysis Stock AnalysisChart About Medipharm Labs Stock (OTCMKTS:MLCPF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medipharm Labs alerts:Sign Up Key Stats Today's Range$0.05▼$0.0650-Day Range$0.04▼$0.0652-Week Range$2.57▼$2.57Volume53,016 shsAverage Volume181,345 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMediPharm Labs Corp. primarily focuses on producing pharma-grade cannabis oil and concentrates in Canada. It also focuses on providing cannabis contract processing services to licensed producers and growers; supplying cannabis oil to companies for sale under its brand; and supplying raw materials and processing for the creation of ready-to-sell cannabis products. The company was founded in 2015 and is headquartered in Barrie, Canada.Read More… Remove Ads Receive MLCPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medipharm Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address MLCPF Stock News HeadlinesMediPharm Labs Shows Strong Q3 GrowthNovember 15, 2024 | markets.businessinsider.comMediPharm Labs Reports Strong Q3 GrowthNovember 15, 2024 | markets.businessinsider.comForget the chainsaw … Here’s DOGE’s next moveDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faster than most people thought … Clearing out waste and inefficiency in our government.March 12, 2025 | Weiss Ratings (Ad)Medipharm Labs Shares Jump on Clearing Remaining DebtSeptember 17, 2024 | marketwatch.comMediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoYAugust 14, 2024 | benzinga.comMediPharm Labs Corp. (LABS.TO)May 23, 2024 | finance.yahoo.comCannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'May 15, 2024 | msn.comMediPharm Labs CorpApril 12, 2024 | morningstar.comSee More Headlines MLCPF Stock Analysis - Frequently Asked Questions How have MLCPF shares performed this year? Medipharm Labs' stock was trading at $0.0443 on January 1st, 2025. Since then, MLCPF stock has increased by 28.8% and is now trading at $0.0570. View the best growth stocks for 2025 here. How do I buy shares of Medipharm Labs? Shares of MLCPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceuticals - Other Sub-IndustryN/A Current SymbolOTCMKTS:MLCPF CIKN/A Webwww.medipharmlabs.com Phone705-719-7425FaxN/AEmployees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (OTCMKTS:MLCPF) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | SponsoredTrump announces revenge on BidenA former CIA insider just made a stunning prediction: Trump’s revenge on Biden will end America’s energy cr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medipharm Labs Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Medipharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
